Effectiveness Assessment of Dapagliflozin as an Add on to Sitagliptin, Vildagliptin and Metformin in Patients with Different Demographic Parameters in Type II DM

ABSTRACT

Objectives The study's goal is to examine the efficacy of various newer anti-diabetic drug combinations that include SGLT2 inhibitors (dapagliflozin), DPP-4 inhibitors (sitagliptin and vildagliptin) and metformin. Materials and Methods Patients with diabetes who had blood glucose levels that were managed (as per the established guidelines), as indicated by Fasting Blood Sugar (FBS) and Postprandial Blood Sugar (PPBS), met the inclusion criteria for this study. Only a person's medical history, medicines and glycemic control are taken consideration in this study. A sample size of 90 samples was included in the study and equally divided among three treatment groups, each of which received a certain treatment option. Each group is once again examined based on gender and the age ranges of 30 to 50 and 51 to 70 years. Results andDiscussion Total 90 samples are considered in the study and divided into 3 group consist of 30 sample size Visit 1 is significant than Visit 2 and Visit 3 and Visit 2 is significant than Visit 3 (p value≤.000). In comparison to the other group, Group 1 achieved a better control of FBS and PPBS levels from Visit 1 to Visit 3, followed by the pharmacological therapy of Dapagliflozin and Sitagliptin. Conclusion The current study establishes for the first time that dapagliflozin, when used in combination with sitagliptin, vildagliptin and metformin, has comparable advantages for improving blood glucose control. When choosing a medicine combination to be used as the first line of treatment for people with type 2 diabetes, it is crucial.

KEYWORDS

• Combination drug therapy
• Dapagliflozin
• Type II Diabetes
• Glycemic control

Showing references and in-text citations exactly as published.

• DOI10.5530/ijper.20255779Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPER.

• Article · VOLUME 59, ISSUE 2Educational Implications of VARK Learning Styles: Academic Performance and Pedagogical Preferences among Korean Pharmacy StudentsSunmin Lee · pp. 512–517Original ArticleSame type: Article
• Article · VOLUME 59, ISSUE 2Materiovigilance: An Emerging Area for Exploration in Pharmaceutical Education-A Comparative Appraisal of Knowledge, Attitudes and Practices among Pharmacists and Healthcare ProfessionalsShareefa Komban, Chandrasekhar Dilip, Kalaiselvan Vivekanandan, Kottilavalappil Hasbiya, Karthika Manazhy, Shyama Sreekumar · pp. 518–529Original ArticleSame type: Article
• Article · VOLUME 59, ISSUE 2Reforming Teaching Methods for Pathology Courses in Traditional Chinese MedicineYang Enyue, Jin Shengyu, Cui Qingsong, Chen Zhengai, Piao Junjie, Jin Guang · pp. 530–534Original ArticleSame type: Article
• Article · VOLUME 59, ISSUE 2Case Study: Effect of CO-PO Mapping and Attainment on Third-Year B Pharm StudentsShilpa Pravin Chaudhari, Priyatama Vijaysing Powar, Sarika Ankushrao Nikam · pp. 535–543Original ArticleSame type: Article